المؤلفون: Clark, Amy S, Yau, Christina, Wolf, Denise M, Petricoin, Emanuel F, van 't Veer, Laura J, Yee, Douglas, Moulder, Stacy L, Wallace, Anne M, Chien, A Jo, Isaacs, Claudine, Boughey, Judy C, Albain, Kathy S, Kemmer, Kathleen, Haley, Barbara B, Han, Hyo S, Forero-Torres, Andres, Elias, Anthony, Lang, Julie E, Ellis, Erin D, Yung, Rachel, Tripathy, Debu, Nanda, Rita, Wulfkuhle, Julia D, Brown-Swigart, Lamorna, Gallagher, Rosa I, Helsten, Teresa, Roesch, Erin, Ewing, Cheryl A, Alvarado, Michael, Crane, Erin P, Buxton, Meredith, Clennell, Julia L, Paoloni, Melissa, Asare, Smita M, Wilson, Amy, Hirst, Gillian L, Singhrao, Ruby, Steeg, Katherine, Asare, Adam, Matthews, Jeffrey B, Berry, Scott, Sanil, Ashish, Melisko, Michelle, Perlmutter, Jane, Rugo, Hope S, Schwab, Richard B, Symmans, W Fraser, Hylton, Nola M, Berry, Donald A, Esserman, Laura J, DeMichele, Angela M

المصدر: Nature communications. 12(1)

مصطلحات موضوعية: Humans, Breast Neoplasms, Paclitaxel, Maytansine, Receptor, erbB-2, Neoadjuvant Therapy, Adult, Aged, Middle Aged, Antibodies, Monoclonal, Humanized, Biomarkers, Tumor, Trastuzumab, Ado-Trastuzumab Emtansine, Receptor, ErbB-2, Clinical Trials and Supportive Activities, Clinical Research, Breast Cancer, Cancer, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/1sh0p1q6

المؤلفون: Clark AS; University of Pennsylvania, Philadelphia, PA, USA. Amy.Clark@pennmedicine.upenn.edu., Yau C; University of California San Francisco, San Francisco, CA, USA., Wolf DM; University of California San Francisco, San Francisco, CA, USA., Petricoin EF; George Mason University, Fairfax, VA, USA., van 't Veer LJ; University of California San Francisco, San Francisco, CA, USA., Yee D; University of Minnesota, Minneapolis, MN, USA., Moulder SL; MD Anderson Cancer Center, Houston, TX, USA., Wallace AM; University of California San Diego, San Diego, CA, USA., Chien AJ; University of California San Francisco, San Francisco, CA, USA., Isaacs C; Georgetown University, Washington, DC, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Albain KS; Loyola University, Chicago, IL, USA., Kemmer K; Oregon Health & Science University, Portland, OR, USA., Haley BB; University of Texas Southwestern, Dallas, TX, USA., Han HS; Moffitt Cancer Center, Tampa, FL, USA., Forero-Torres A; University of Alabama Birmingham, Birmingham, AL, USA., Elias A; University of Colorado Denver, Aurora, CO, USA., Lang JE; University of Southern California, Los Angeles, CA, USA., Ellis ED; Swedish Cancer Institute, Seattle, WA, USA., Yung R; University of Washington, Seattle, WA, USA., Tripathy D; MD Anderson Cancer Center, Houston, TX, USA., Nanda R; University of Chicago, Chicago, IL, USA., Wulfkuhle JD; MD Anderson Cancer Center, Houston, TX, USA., Brown-Swigart L; University of California San Francisco, San Francisco, CA, USA., Gallagher RI; MD Anderson Cancer Center, Houston, TX, USA., Helsten T; University of California San Diego, San Diego, CA, USA., Roesch E; University of California San Diego, San Diego, CA, USA., Ewing CA; University of California San Francisco, San Francisco, CA, USA., Alvarado M; University of California San Francisco, San Francisco, CA, USA., Crane EP; Georgetown University, Washington, DC, USA., Buxton M; Berry Consultants, LLC, Houston, TX, USA., Clennell JL; Berry Consultants, LLC, Houston, TX, USA., Paoloni M; Berry Consultants, LLC, Houston, TX, USA., Asare SM; University of California San Francisco, San Francisco, CA, USA., Wilson A; University of California San Francisco, San Francisco, CA, USA., Hirst GL; University of California San Francisco, San Francisco, CA, USA., Singhrao R; University of California San Francisco, San Francisco, CA, USA., Steeg K; University of California San Francisco, San Francisco, CA, USA., Asare A; University of California San Francisco, San Francisco, CA, USA., Matthews JB; University of California San Francisco, San Francisco, CA, USA., Berry S; Berry Consultants, LLC, Houston, TX, USA., Sanil A; Berry Consultants, LLC, Houston, TX, USA., Melisko M; University of California San Francisco, San Francisco, CA, USA., Perlmutter J; Gemini Group, Ann Arbor, MI, USA., Rugo HS; University of California San Francisco, San Francisco, CA, USA., Schwab RB; University of California San Diego, San Diego, CA, USA., Symmans WF; MD Anderson Cancer Center, Houston, TX, USA., Hylton NM; University of California San Francisco, San Francisco, CA, USA., Berry DA; Berry Consultants, LLC, Houston, TX, USA., Esserman LJ; University of California San Francisco, San Francisco, CA, USA., DeMichele AM; University of Pennsylvania, Philadelphia, PA, USA.

المصدر: Nature communications [Nat Commun] 2021 Nov 05; Vol. 12 (1), pp. 6428. Date of Electronic Publication: 2021 Nov 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Ado-Trastuzumab Emtansine/*therapeutic use , Breast Neoplasms/*drug therapy , Neoadjuvant Therapy/*methods, Adult ; Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Biomarkers, Tumor ; Humans ; Maytansine/therapeutic use ; Middle Aged ; Paclitaxel/therapeutic use ; Receptor, ErbB-2/therapeutic use ; Trastuzumab/therapeutic use